{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:06:33Z","timestamp":1789772793372,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["960988"],"award-info":[{"award-number":["960988"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.tice.2025.102830","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T08:02:21Z","timestamp":1741075341000},"page":"102830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Formulation and development of ACUPA-targeting PEGylated nanoliposomes for treatment of prostate cancer"],"prefix":"10.1016","volume":"95","author":[{"given":"Seyedeh Alia","family":"Moosavian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Reza","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Hoda","family":"Alavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0890-769X","authenticated-orcid":false,"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2025.102830_bib1","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1002\/jcp.29339","article-title":"PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells","volume":"235","author":"Afsharzadeh","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tice.2025.102830_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0014-5793(87)80506-9","article-title":"Large unilamellar liposomes with low uptake into the reticuloendothelial system","volume":"223","author":"Allen","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tice.2025.102830_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Biomembr."},{"key":"10.1016\/j.tice.2025.102830_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijpharm.2013.10.018","article-title":"Improvement of pharmacokinetic and antitumor activity of PEGylated liposomal doxorubicin by targeting with N-methylated cyclic RGD peptide in mice bearing C-26 colon carcinomas","volume":"458","author":"Amin","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.tice.2025.102830_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/cgt.2017.9","article-title":"The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: A systematic review of clinical trials","volume":"24","author":"Ansari","year":"2017","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tice.2025.102830_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2015.10.044","article-title":"Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin","volume":"220","author":"Arabi","year":"2015","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.tice.2025.102830_bib7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaoncol.2018.2168","article-title":"Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial","volume":"4","author":"Autio","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.tice.2025.102830_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(R)--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.tice.2025.102830_bib9","first-page":"2674","article-title":"Prostate-specific membrane antigen is produced in tumor-associated neovasculature","volume":"5","author":"Chang","year":"1999","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.tice.2025.102830_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/inorganics12120331","article-title":"Platinum\u2013Iron Nanoparticles for Oxygen-Enhanced Sonodynamic Tumor Cell Suppression","volume":"12","author":"Dong","year":"2024","journal-title":"Inorganics"},{"key":"10.1016\/j.tice.2025.102830_bib11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.tice.2025.102830_bib12","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1073\/pnas.0601755103","article-title":"Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo","volume":"103","author":"Farokhzad","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tice.2025.102830_bib13","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1073\/pnas.0601755103","article-title":"Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo","volume":"103","author":"Farokhzad","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tice.2025.102830_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0005-2736(92)90061-P","article-title":"The role of surface charge and hydrophilic groups on liposome clearance in vivo","volume":"1103","author":"Gabizon","year":"1992","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Biomembr."},{"key":"10.1016\/j.tice.2025.102830_bib15","article-title":"Role of nanoparticles in enhancing chemotherapy efficacy for cancer treatment","volume":"2","author":"Ghazal","year":"2024","journal-title":"Materials"},{"key":"10.1016\/j.tice.2025.102830_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/978-1-59745-483-4_37","article-title":"Formulation\/preparation of functionalized nanoparticles for in vivo targeted drug delivery","volume":"544","author":"Gu","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tice.2025.102830_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jconrel.2024.07.067","article-title":"Nanomaterials for bone metastasis","volume":"373","author":"Hao","year":"2024","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.tice.2025.102830_bib18","doi-asserted-by":"crossref","first-page":"12417","DOI":"10.1039\/D1CC04846E","article-title":"Nanoscale covalent organic frameworks: from controlled synthesis to cancer therapy","volume":"57","author":"He","year":"2021","journal-title":"Chem. Commun."},{"key":"10.1016\/j.tice.2025.102830_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tice.2025.102830_bib20","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1002\/anie.200900111","article-title":"Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery","volume":"48","author":"Huang","year":"2009","journal-title":"Angew. Chem. (Int. Ed. Engl. )"},{"key":"10.1016\/j.tice.2025.102830_bib21","doi-asserted-by":"crossref","first-page":"15702","DOI":"10.1021\/ja8065557","article-title":"Sterol-modified phospholipids: cholesterol and phospholipid chimeras with improved biomembrane properties","volume":"130","author":"Huang","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tice.2025.102830_bib22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tice.2025.102830_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112200","article-title":"PSMA Ligand Conjugated PCL-PEG Polymeric Micelles Targeted to Prostate Cancer Cells","volume":"9","author":"Jin","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.tice.2025.102830_bib24","doi-asserted-by":"crossref","first-page":"6732","DOI":"10.1158\/0008-5472.CAN-05-4199","article-title":"Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models","volume":"66","author":"Kirpotin","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.tice.2025.102830_bib25","article-title":"Multifunctional Biomimetic Liposomes with Improved Tumor-Targeting for TNBC Treatment by Combination of Chemotherapy, Antiangiogenesis and Immunotherapy","volume":"13","author":"Lan","year":"2024","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.tice.2025.102830_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/533304a","article-title":"Bankruptcy filing worries developers of nanoparticle cancer drugs","volume":"533","author":"Ledford","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tice.2025.102830_bib27","doi-asserted-by":"crossref","unstructured":"Li, K., Wang, Q., Tang, X., Akakuru, O.U., Li, R., Wang, Y., Zhang, R., Jiang, Z., Yang, Z., Advances in Prostate Cancer Biomarkers and Probes. Cyborg and Bionic Systems 5, 0129.","DOI":"10.34133\/cbsystems.0129"},{"key":"10.1016\/j.tice.2025.102830_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/biom9090421","article-title":"Tumor Uptake of Triazine Dendrimers Decorated with Four, Sixteen, and Sixty-Four PSMA-Targeted Ligands: Passive versus Active Tumor Targeting","volume":"9","author":"Lim","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.tice.2025.102830_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","article-title":"A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging","volume":"10","author":"Linders","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.tice.2025.102830_bib30","doi-asserted-by":"crossref","first-page":"50569","DOI":"10.1021\/acsami.2c15095","article-title":"Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers","volume":"14","author":"Meher","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.tice.2025.102830_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2019.01.045","article-title":"Aptamer-functionalized liposomes for targeted cancer therapy","volume":"448","author":"Moosavian","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2025.102830_bib32","first-page":"2054","article-title":"5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells","volume":"46","author":"Moosavian","year":"2018","journal-title":"Artif. Cells, Nanomed., Biotechnol."},{"key":"10.1016\/j.tice.2025.102830_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.colsurfb.2015.12.009","article-title":"Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model","volume":"139","author":"Moosavian","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.tice.2025.102830_bib34","article-title":"Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy","author":"Moosavian","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tice.2025.102830_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.semcancer.2019.09.025","article-title":"Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy","volume":"69","author":"Moosavian","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tice.2025.102830_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2019.01.045","article-title":"Aptamer-functionalized liposomes for targeted cancer therapy","volume":"448","author":"Moosavian","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tice.2025.102830_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119513","article-title":"Metal organic framework coated MnO(2) nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer","volume":"585","author":"Nie","year":"2020","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.tice.2025.102830_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.lfs.2018.03.023","article-title":"Toxicity of Doxorubicin (Dox) to different experimental organ systems","volume":"200","author":"Pugazhendhi","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.tice.2025.102830_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of Prostate Cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.tice.2025.102830_bib40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/mp100360g","article-title":"Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents","volume":"8","author":"Sanna","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tice.2025.102830_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1874471012666190729151540","article-title":"Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications","volume":"13","author":"Sara","year":"2020","journal-title":"Curr. Radiopharm."},{"key":"10.1016\/j.tice.2025.102830_bib42","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.1073\/pnas.0905487106","article-title":"Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements","volume":"106","author":"Schluep","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tice.2025.102830_bib43","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: progress, challenges and opportunities","volume":"17","author":"Shi","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tice.2025.102830_bib44","first-page":"81","article-title":"Prostate-specific membrane antigen expression in normal and malignant human tissues","volume":"3","author":"Silver","year":"1997","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.tice.2025.102830_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110683","article-title":"Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery","volume":"158","author":"Singh","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.tice.2025.102830_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.694363","article-title":"Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges","volume":"9","author":"Sun","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tice.2025.102830_bib47","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.addr.2013.08.012","article-title":"Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status","volume":"65","author":"van der Meel","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tice.2025.102830_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40164-023-00444-9","article-title":"Recent advances and future perspectives in the therapeutics of prostate cancer","volume":"12","author":"Varaprasad","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.tice.2025.102830_bib49","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.tice.2025.102830_bib50","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor Cell-Targeting and Tumor Microenvironment-Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic\/Photothermal\/Chemodynamic Treatment of Cervical Cancer","volume":"19","author":"Wang","year":"2024","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.tice.2025.102830_bib51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","article-title":"Involvement of ROS\/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity","volume":"20","author":"Wei","year":"2020","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.tice.2025.102830_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110525","article-title":"NF-kappaB pathway activation during endothelial-to-mesenchymal transition in a rat model of doxorubicin-induced cardiotoxicity","volume":"130","author":"Xu","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.tice.2025.102830_bib53","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1002\/jcp.26361","article-title":"Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy","volume":"233","author":"Zamani","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tice.2025.102830_bib54","article-title":"A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway","volume":"17","author":"Zhang","year":"2016","journal-title":"Int. J. Mol. Sci."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T15:25:45Z","timestamp":1750260345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816625001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":54,"alternative-id":["S0040816625001107"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.102830","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and development of ACUPA-targeting PEGylated nanoliposomes for treatment of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.102830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102830"}}